3D Medicines, Inc. (HK:1244) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
3D Medicines Inc. has announced a change in its auditor, with Ernst & Young set to retire after the upcoming annual general meeting on June 28, 2024, due to an unresolved agreement on audit fees. The company’s board, following an audit committee recommendation, proposes appointing Modern Assure CPA Limited as the new auditor, pending shareholder approval at the AGM. There were no disagreements or unresolved matters reported between Ernst & Young and 3D Medicines Inc.
For further insights into HK:1244 stock, check out TipRanks’ Stock Analysis page.